Reading Drug Structures from Their Names (5): The "Statin" Key is the Dihydroxy Acid
――A family that "mimics" HMG-CoA reductase
Introduction
The 5th installment of this series is "-statin". This is the suffix stem for HMG-CoA reductase (HMGCR) inhibitors, commonly known as "statins".
Simvastatin, lovastatin, pravastatin, fluvastatin, atorvastatin, rosuvastatin, pitavastatin, cerivastatin (withdrawn)... they all end in "-statin". Once you look at the suffix, the key molecular component, "a dihydroxy acid that mimics the HMG-CoA of the mevalonate pathway", will immediately come to mind.
The true nature of the "-statin" stem
The stem "-statin" is a classical suffix meaning "inhibitor" (derived from "stat = to stop," also used in pepstatin, pentastatin, etc.), and in pharmaceutical nomenclature, it is assigned to HMG-CoA reductase inhibitors.
The common structural features of statins are the following three points:
3,5-dihydroxypentanoic acid (−CH(OH)−CH₂−CH(OH)−CH₂−COOH) or the δ-lactone form
A large hydrophobic scaffold extending from it (decalin, pyrrole, indole, pyrimidine, etc.)
The part that "resembles" HMG-CoA is the dihydroxy acid: it mimics the "3-hydroxy-3-methylglutaryl" terminus of HMG-CoA
HMGCR is the rate-limiting enzyme of the mevalonate pathway and its job is to reduce HMG-CoA to mevalonic acid. Statins have a shape that is identical to the "acid part" of HMG-CoA, and they sit in the active pocket of HMGCR to block the reduction reaction from NADPH. In the sense of inhibiting a receptor/enzyme by mimicking its substrate, this is the same concept as the "-pril" (proline mimic) from the previous installment.
Case 1: Atorvastatin (a representative synthetic statin)
Atorvastatin, one of the most prescribed statins in the world. Its structure can be read by dividing it into two parts.
Red: 3,5-dihydroxy-pentanoic acid (the "key" that inhibits HMGCR)
Left side: A hydrophobic scaffold consisting of a pyrrole ring + 3 benzene rings + F, t-Bu (fills the hydrophobic pocket around HMGCR)
If you can read it as "the red part is the active center of the enzyme, and the hydrophobic part on the left fills the surrounding pocket to increase residence time," then high lipophilicity → easily accumulates in the liver → effective at lowering plasma cholesterol—the typical behavior of a statin—naturally follows.
Atorvastatin, rosuvastatin, fluvastatin, pitavastatin, etc., are fully synthetic systems. Lovastatin, simvastatin, and pravastatin are derived from natural products (fungal metabolites) or are semi-synthetic systems, and possess a decalin ring skeleton. There are two lineages in the family.
Case 2: Rosuvastatin (high potency + hydrophilic)
Rosuvastatin is a representative of the high-potency type, often called a "super-statin".
Red: Also 3,5-dihydroxy-pentanoic acid (the key remains the same)
Left side: pyrimidine ring + fluorophenyl + methylsulfonylamino group
The focus is on the "methylsulfonylamino group (-SO₂N(Me)Me)" at the bottom left. This forms hydrogen bonds/polar interactions with specific residues within the HMGCR active pocket, increasing binding affinity by orders of magnitude. At the same time, this polar group lowers the logP of the entire molecule, making it hydrophilic (logP ≒ 0.1), which leads to behaviors such as being taken up into the liver by the OATP1B1 transporter, and being metabolized in small amounts by CYP2C9, with the unchanged drug excreted in bile.
Statin Overview: Distinguishing between Natural Products and Synthetic Systems
Natural product-based (decalin skeleton): Lovastatin, simvastatin, pravastatin — decalin ring + δ-lactone, CYP3A4 system
Synthetic-based (heterocyclic skeleton): Fluvastatin (indole), atorvastatin (pyrrole), rosuvastatin (pyrimidine), pitavastatin (quinoline) — free acid form, less CYP influence
On "Lactone Form" vs. "Acid Form"
Natural product-based statins are administered in the δ-lactone form, which opens in the body to be converted into the free dihydroxy acid before inhibiting HMGCR. Most synthetic types are in the acid form from the start. This difference is directly linked to oral absorption rates and the presence or absence of food effects.
Summary
-statin is the suffix stem for HMG-CoA reductase inhibitors
The common skeleton is 3,5-dihydroxy-pentanoic acid (or δ-lactone) + hydrophobic scaffold
Natural product-based (decalin ring + CYP3A4) and synthetic-based (heterocycle + less CYP influence) are the two lineages
Rosuvastatin's methylsulfonylamino group achieves both hydrophilicity and high potency
Next Preview
Next time: "-prazole". We will decode the suffix stem for proton pump inhibitors (PPIs), the three-part set of benzimidazole + sulfoxide + pyridine, and the mechanism of "activation by acid".